Apertura Gene Therapy and Scientists from the Broad Institute to Share Data on TfR1 CapX™, a Novel Capsid Targeting the Central Nervous System (CNS), at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

— Presentations show that TfR1 CapX™ is being manufactured at clinical scale, a major hurdle in gene therapy development, and illustrate the importance of human-relevant preclinical models for gene therapy development — — Presentations on Open Aperture, Apertura's material transfer...